Accession Number: | 0001179110-20-007793 |
Date: | 2020-06-24 |
Issuer: | BLUEPRINT MEDICINES CORP (BPMC) |
Original Submission Date: |
ROWLAND CHARLES A JR
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-24 | A | 2,250 | a | $0.00 | 3,562 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 76.24 | 2020-06-24 | deemed execution date | A | 4,500 (a) | 2030-06-24 | common stock 4,500 | $76.24 | 4,500 | direct |
ID | footnote |
---|---|
f1 | the reported transaction involved the reporting person's receipt of a grant of restricted stock units. the restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) the next annual meeting of the issuer's stockholders and (ii) june 24, 2021. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
f2 | this option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the issuer's stockholders and (ii) june 24, 2021. |